Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02873936
What this trial is testing

Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 449
Not applicableStudy completedNCT01641952
What this trial is testing

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 505
Large-scale testing (Phase 3)Study completedNCT02001987
What this trial is testing

Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 139
Large-scale testing (Phase 3)Study completedNCT02766816
What this trial is testing

A Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven Biologicals

Who this might be right for
Immune Response to Oral Polio Vaccine
Bilthoven Biologicals 1,120
Testing effectiveness (Phase 2)Study completedNCT00303563
What this trial is testing

P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 204
Early research (Phase 1)Study completedNCT02470637
What this trial is testing

Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Mannkind Corporation 30
Large-scale testing (Phase 3)Study completedNCT00377637
What this trial is testing

Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 370
Large-scale testing (Phase 3)Study completedNCT00106574
What this trial is testing

Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,220
Post-approval studies (Phase 4)Study completedNCT00462345
What this trial is testing

MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 40
Large-scale testing (Phase 3)Study completedNCT01610791
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs (REMISSION)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 121
Not applicableStudy completedNCT00242853
What this trial is testing

Investigate Markers Of Inflammation In Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisOsteoarthritis
GlaxoSmithKline 48
Large-scale testing (Phase 3)Study completedNCT00124982
What this trial is testing

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,286
Testing effectiveness (Phase 2)Study completedNCT01888874
What this trial is testing

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 599
Testing effectiveness (Phase 2)Study completedNCT03518125
What this trial is testing

BARDA Securing Anthrax Immunity For the Elderly

Who this might be right for
Anthrax
Biomedical Advanced Research and Development Authority 305
Testing effectiveness (Phase 2)Study completedNCT04413617
What this trial is testing

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Who this might be right for
Rheumatoid Arthritis
Pfizer 460
Not applicableStudy completedNCT03653676
What this trial is testing

Sickle Cell Pro-Inflammatory Response to Interval Training Study

Who this might be right for
Sickle Cell Disease
Ann & Robert H Lurie Children's Hospital of Chicago 110
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Not applicableStudy completedNCT02559037
What this trial is testing

Acupuncture Treatment for Active Crohn's Disease

Who this might be right for
Crohn's Disease
Shanghai Institute of Acupuncture, Moxibustion and Meridian 66
Not applicableUnknownNCT01089036
What this trial is testing

Oxidant-antioxidant Activity, Free Radicle Activity, Immune Response and Biomarkers in Extracorporeal Membrane Oxygenation (ECMO) Patients

Who this might be right for
Cardiogenic ShockAcute Myocardial InfarctionMyocarditis+1 more
National Taiwan University Hospital 100
Not applicableUnknownNCT05119738
What this trial is testing

Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment

Who this might be right for
Sars-CoV-2 Infection
Pontificia Universidad Catolica de Chile 122
Next Page